TrialSignal
Clinical trial intelligence report
Ginger and the Microbiota-gut-brain Connection in Sciatic Pain Individuals
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT06817018-Jul 28, 2026
NCT ID
NCT06817018
Status
RECRUITING
Phase
PHASE2
Sponsor
Leslie Shen
Executive brief
Investment-Ready Snapshot
Ginger and the Microbiota-gut-brain Connection in Sciatic Pain Individuals is a PHASE2 clinical asset sponsored by Leslie Shen in Neuropathic Pain, Sciatic Pain. SEO and diligence focus: Placebo, Ginger, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT06817018
Indication
Neuropathic Pain
Modality
small molecule
Target
Placebo, Ginger
Intervention
Placebo, Ginger
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.